Details for New Drug Application (NDA): 020312
✉ Email this page to a colleague
The generic ingredient in UNIVASC is moexipril hydrochloride. There are seven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the moexipril hydrochloride profile page.
Summary for 020312
Tradename: | UNIVASC |
Applicant: | Ucb Inc |
Ingredient: | moexipril hydrochloride |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Apr 19, 1995 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Apr 19, 1995 | TE: | RLD: | No |
Expired US Patents for NDA 020312
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ucb Inc | UNIVASC | moexipril hydrochloride | TABLET;ORAL | 020312-002 | Apr 19, 1995 | ⤷ Sign Up | ⤷ Sign Up |
Ucb Inc | UNIVASC | moexipril hydrochloride | TABLET;ORAL | 020312-001 | Apr 19, 1995 | ⤷ Sign Up | ⤷ Sign Up |
Ucb Inc | UNIVASC | moexipril hydrochloride | TABLET;ORAL | 020312-002 | Apr 19, 1995 | ⤷ Sign Up | ⤷ Sign Up |
Ucb Inc | UNIVASC | moexipril hydrochloride | TABLET;ORAL | 020312-001 | Apr 19, 1995 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription